News | 08 August 2012
U.S. negotiators in September proposed eliminating duties on medicines and setting a deadline for drug companies to bring their products to market by giving them access to nations in the pact and creating a ?pathway? for generics. The strategy is aimed ...
Click on the link to read the full article at Bloomberg
(This link will open in a new window)